Stem Cells International

Stem Cells International / 2019 / Article

Research Article | Open Access

Volume 2019 |Article ID 8589149 | 15 pages | https://doi.org/10.1155/2019/8589149

Preconditioning of Human Dental Pulp Stem Cells with Leukocyte- and Platelet-Rich Fibrin-Derived Factors Does Not Enhance Their Neuroregenerative Effect

Academic Editor: Darius Widera
Received15 Nov 2018
Revised22 Jan 2019
Accepted12 Feb 2019
Published08 Apr 2019

Abstract

Pathologies of the central nervous system are characterized by loss of brain tissue and neuronal function which cannot be adequately restored by endogenous repair processes. This stresses the need for novel treatment options such as cell-based therapies that are able to restore damaged tissue or stimulate repair. This study investigated the neuroregenerative potential of the conditioned medium of human dental pulp stem cells (CM-hDPSCs) on neural stem cell (NSC) proliferation and migration as well as on neurite outgrowth of primary cortical neurons (pCNs). Additionally, the effect of leukocyte- and platelet-rich fibrin (L-PRF) priming on the neuroregenerative potential of the hDPSC secretome on NSCs and pCNs was evaluated. L-PRF contains factors that enhance stem cell-induced regeneration, but its effect on hDPSC-mediated neuroregeneration is unknown. This study demonstrated that CM-hDPSCs enhanced neuritogenesis. Moreover, CM-hDPSCs had a chemoattractant effect on NSCs. Although priming hDPSCs with L-PRF increased brain-derived neurotrophic factor secretion, no additional effects on the paracrine-mediated repair mechanisms were observed. These data support the neuroregenerative potential of hDPSCs, and although priming had no additional effect, the potential of L-PRF-primed hDPSCs on distinct regenerative mechanisms remains to be clarified.

1. Introduction

Pathologies of the central nervous system (CNS), such as stroke, are one of the main causes of death and new cases of permanent disabilities which are characterized by tissue damage and loss of brain function [1]. The lost tissue can only be partially reconstituted by the host, for example, via endogenous neural stem cells (NSCs) that migrate towards the injury. However, this regenerative response is ineffective and novel therapies, such as cell-based therapies are needed for treating these disorders. Ideally, NSCs or neural precursor cells (NPCs) would be used as a (stem) cell source as these cells have the potential to differentiate into the majority of neuronal cell types present in the adult brain [2] but due to ethical and practical issues with NSCs, an easily accessible alternative stem cell-source with a neuroregenerative potential is needed.

Human dental pulp stem cells (hDPSCs), neural crest-derived stem cells with mesenchymal stem cell (MSC) characteristics, are an attractive alternative for NSCs or NPCs. Our group and others have previously shown that hDPSCs are characterized by MSC properties as determined by the International Society for Cellular Therapy based on their differentiation potential and surface marker expression [36]. In addition to classical multilineage MSC differentiation, we have demonstrated that hDPSCs are capable of neuronal [7] and Schwann cell differentiation [8] in vitro. Moreover, it is described that hDPSCs can enhance neuroregeneration via several mechanisms, including cell replacement, neuroprotection, and immunomodulation, and by promoting neuroplasticity and angiogenesis [7, 913]. As these mechanisms were mainly thought to be mediated by paracrine actions of the hDPSCs, our group recently investigated the effect of the hDPSC secretome on human SH-SY5Y neuroblastoma cells with encouraging results on hDPSC-driven chemoattraction and neuritogenesis [14]. However, it remains to be determined if these hDPSC-mediated effects can also be observed in cells which are more relevant to the target CNS cells when considering in vivo applications of the hDPSC secretome.

Additionally, this study assessed whether preconditioning of hDPSCs enhances their neuroregenerative potential. If hDPSCs are to be considered as a stem cell-based therapy for neurodegenerative disorders, it is important to take the effect of the hypoxic/ischemic and inflammatory microenvironment in which the transplanted cells are situated into account. Several studies have already tried to precondition or “prime” stem cells with hypoxia or with in vitro hypoxia mimetics, which was shown to enhance the proangiogenic properties of periodontal ligament stem cells [15] and hDPSCs [16]. Moreover, the trophic effect of hDPSCs on SH-SY5Y cells was enhanced [17], and the secretion of vascular endothelial growth factor (VEGF) was increased [18]. Another approach to prime hDPSCs is to expose them to a cocktail of key components of the inflammatory reaction, which can be found in the blood. Therefore, we evaluated whether leukocyte- and platelet-rich fibrin (L-PRF), a blood-derived biomaterial that is used in the clinic, can enhance the neuroregenerative effect of hDPSCs. L-PRF has shown great promise in wound healing and bone restoration [19, 20], and its therapeutic effect is thought to be mediated by the release of growth factors and cytokines present in this material [21, 22].

In this study, L-PRF is hypothesized to contain multiple (inflammatory) components that modify the stem cell properties and neuroregenerative potential of hDPSCs, an approach that to our knowledge has not been used before. L-PRF is known to contain tumour necrosis factor alpha (TNF-α) [23], insulin-like growth factor 1 (IGF-1) [22], and interleukin 1 beta (IL-1β) [22] that can influence stem cell characteristics and behaviour. TNF-α was shown to enhance the stem cell properties of hDPSCs [24] and the neuronal fate of bone marrow-derived mesenchymal stem cells (BMSCs) [25]. In addition, IGF-1 enhanced the proliferation of BMSCs [26] and TNF-α signalling shifted the secretome of adipose-derived stem cells towards a proangiogenic profile [27]. It was demonstrated that IL-1β promoted the immunomodulatory properties of human umbilical cord MSCs [28]. Moreover, TNF-α-, IGF-1-, and IL-1β-stimulated MSCs also increased the expression of CXCR4, a receptor for the chemokine stromal-derived factor-1 (SDF-1). SDF-1 is released by the injured brain which may enhance the migratory capacity of MSCs towards the site of brain injury [25, 26, 28, 29]. MSCs exposed to IL-10 and interferon gamma (IFN-γ) producing type 1 regulatory T cells acquire an immunomodulatory phenotype [30], and the secretome of MSCs primed with IL-1β or IL-1α was shown to reduce the secretion of inflammatory mediators in lipopolysaccharide-activated microglia, demonstrating an immunomodulatory effect of MSC priming [31]. However, the effect of L-PRF on enhancing the neuroregenerative effect of hDPSCs or other MSC subtypes remains elusive.

L-PRF clots are obtained from venous whole blood samples which can be mechanically compressed. During this process, the fluid containing growth factors residing in the clot can be isolated and is termed the L-PRF exudate (EX L-PRF). The factors present in the clot or bound to the fibrin matrix can also be isolated by keeping the clot in culture after which the conditioned culture medium (CM L-PRF) can be collected which then contains the factors that are being released over time.

This study was aimed at evaluating paracrine-mediated effects of hDPSCs on mouse NSCs and primary cortical neurons (pCNs). The influence of the hDPSC secretome on NSC proliferation and migration was assessed. Moreover, the influence of the hDPSC factors on neurite outgrowth of pCNs was investigated. In order to evaluate the effect of L-PRF priming on hDPSCs, the optimal priming conditions were determined. hDPSCs were exposed to various concentrations of EX/CM L-PRF to investigate the mitogenic and metabolic effect of L-PRF on hDPSCs. Moreover, a growth factor array was used to determine the composition of both L-PRF subfractions. Additionally, hDPSCs were exposed to EX/CM L-PRF in different concentrations for various time points in order to evaluate enhanced growth factor production by hDPSCs. Brain-derived neurotrophic factor (BDNF) secretion was used as a measure for enhanced neurotrophin production as this factor was previously shown to be secreted by hDPSCs [7, 32] and was demonstrated to enhance functional recovery and neurogenesis [33, 34]. Afterwards, the conditioned medium of primed hDPSCs (prCM-hDPSCs) was used in the assays on NSCs and pCNs (vide supra) in parallel with CM-hDPSCs to evaluate the effect of L-PRF priming on hDPSC-mediated mechanisms of neuroregeneration.

2. Materials and Methods

2.1. Isolation and Cell Culture of hDPSCs

Human dental pulp tissue was obtained from patients of both genders aged 14 to 26 () undergoing routine extraction of third molars for orthodontic reasons with informed consent of the patient or after approval of the legal guardian. This study was approved by the Medical Ethical Committee of Hasselt University (13/0104u). All experiments were performed in accordance with the guidelines and regulations of the host institution. Subsequently, hDPSCs were isolated by the explant method as described previously [4, 5, 7]. Briefly, the tooth was fractioned mechanically after which the dental pulp tissue was isolated with sterile forceps. Afterwards, the tissue was rinsed in standard hDPSC medium which consists of alpha modification of minimum essential medium (α-MEM) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and 10% foetal bovine serum (FBS). Next, the pulp was cut into small fragments of 1-2 mm3 which were grown in 6-well plates and incubated at 37°C in a humidified atmosphere containing 5% CO2. The culture medium was changed every 3-4 days and after reaching 70-80% confluency, the cells were harvested using 0.05% trypsin with ethylenediaminetetraacetic acid (EDTA). For further expansion, hDPSCs were seeded at a density of cells/cm2 and the cell culture was evaluated on a regular basis with a Nikon Eclipse TS100 inverted phase contrast microscope equipped with a Jenoptik ProgRes C3 camera (Jenoptik, Jena, Germany) with corresponding ProgRes Capture Pro 2.7 software. All experiments were conducted with hDPSCs between passages two and eight. All chemicals, supplements, and media were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless stated otherwise.

2.2. Isolation and Culture of L-PRF

L-PRF was isolated from healthy donors of both genders, aged 25 to 54 (). Isolation was approved by the medical ethical committee of Hasselt University and the Clinical Trial Center from KU Leuven (S58789/B322201628215/I/U). L-PRF was prepared according to the guidelines of the IntraSpin™ Centrifuge (Intra-Lock International, Boca Raton, FL, USA). Briefly, 9 ml venous blood samples were collected in glass-coated plastic tubes (VACUETTE® Z Serum Clot Activator Tubes; Greiner Bio-One, Kremsmünster, Austria) and spun down for 12 min at 400 g. Afterwards, L-PRF clots were collected and coagulated red blood cells were removed. The resulting clots were then transferred to the Xpression™ Box (Intra-Lock International), and a weighted press was put onto the clots. This device extracts exudate (EX) L-PRF from the clot in a controlled manner and results in a thin compressed layer of L-PRF with consistent thickness. The exudate was sterile filtered, aliquoted, and stored at -80°C for later use. L-PRF clots were transferred to 6-well plates and put in culture in alpha modification of minimum essential medium (α-MEM) without FBS but containing 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin for 96 h. Afterwards, the CM L-PRF was collected, sterile filtered, aliquoted, and stored at -80°C. Figure 1 provides a schematic overview that describes CM L-PRF and EX L-PRF preparation.

2.3. Human Cytokine Antibody Array

A cytokine antibody array (ab133998; Abcam, Cambridge, UK) was performed on CM and EX L-PRF () at a protein concentration of 10 mg/ml according to the manufacturer’s instructions. Protein concentrations of the samples were determined with a bicinchoninic acid assay (BCA; Thermo Fisher Scientific, Waltham, MA, USA) following the user manual. Relative pixel density was measured using Fiji software to compare relative protein levels between EX and CM L-PRF. This analysis was previously performed by our research group [35]. This study reinterpreted the data of these arrays focusing on the inflammatory factors present in both L-PRF subfractions.

2.4. Metabolic Activity and Proliferation of hDPSCs Exposed to L-PRF

The relative metabolic and mitotic activities of hDPSCs exposed to CM/EX L-PRF () were evaluated by means of a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and propidium iodide (PI) assay, respectively. The latter takes the amount of PI intercalating between DNA as a measure for the total number of cells. The average values of 3 different hDPSC donors were calculated, primed with 5 different L-PRF donors in 5 independent experiments. hDPSCs were seeded in triplicate at a density of cells/cm2 in 96-well plates in standard hDPSC medium. After 24 h, the medium was discarded and hDPSCs were exposed to 1%, 2%, 5%, and 10% CM/EX L-PRF for 24 h, 48 h, or 72 h. hDPSCs exposed to hDPSC standard medium without FBS and with 10% FBS were used as a negative and positive control, respectively. To perform the MTT assay at each time point, the medium was removed and 500 μg/ml MTT was added. After 4 h of incubation, the MTT-containing solution was removed and 0.01 M of glycine in DMSO was added to the wells in order to dissolve the formed formazan crystals. The absorbance was measured at 570 nm and corrected for the background signal at 655 nm with an iMark™ Microplate Reader (Bio-Rad).

The PI assay was performed by removing the medium and adding 75 μl of lysis buffer to each well (ChemoMetec, Allerod, Denmark) after which 75 μl of stabilizing solution (ChemoMetec) containing PI (10 μg/ml) was added and incubated at room temperature in the dark for 15 min. Afterwards, the solution was transferred to a black 96-well plate and fluorescence was excited at 540 nm and measured at 612 nm with a Fluostar Optima (BMG Labtech, Ortenberg, Germany). All data were normalized to the values of hDPSCs exposed to standard hDPSC medium without FBS after 24 h exposure.

2.5. Priming of hDPSCs with L-PRF Exudate and Conditioned Medium

hDPSCs from two different donors were primed with four different CM/EX L-PRF donors in various concentrations (1%, 5%, and 10%) in standard hDPSC medium without FBS. Cells were seeded at cells/cm2 in standard hDPSC medium. After plastic adherence, the medium was removed and serum-free hDPSC medium supplemented with the appropriate concentration of CM/EX L-PRF was added to prime the cells. After 24 h or 48 h, this priming medium was removed and the cells were thoroughly washed with phosphate-buffered saline (PBS). Next, serum-free Neurobasal-A medium (Invitrogen; Carlsbad, CA, USA) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin was added to the hDPSCs. 48 h later, the medium was collected, centrifuged at 300 g for 6 min, aliquoted, and stored at -80°C for later use. The cell number of all conditions was determined with a Moxi cell counter (ORFLO Technologies, Ketchum, ID, USA).

The inductive effect of EX L-PRF and CM L-PRF on the growth factor production of hDPSCs was determined by means of a BDNF ELISA according to the instructions of the manufacturer (RayBiotech®; Norcross, GA, USA). The BDNF concentration was normalized to cells to correct for variations in cell number due to the priming conditions.

2.6. Preparation of Conditioned Medium of hDPSCs and hDPSCs Primed with L-PRF

In order to prepare the conditioned medium of primed (prCM-hDPSCs) and nonprimed hDPSCs (CM-hDPSCs), cells ( hDPSC donors) were seeded at a density of 1 cells/cm2 in standard culture medium. After the cells adhered to the surface, the medium was changed to 1 ml/5 cm2 of serum-free hDPSC medium with or without 10% EX L-PRF from 3 different donors. 48 h later, the cells were rinsed with PBS and the medium was changed to serum-free Neurobasal-A medium, supplemented with 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin for 48 h to allow EX L-PRF-induced secretion of growth factors. After 48 h, the medium was collected, centrifuged at 300 g, aliquoted, and stored at -80°C for later use. In addition, the cells were counted to later normalize prCM-hDPSC volumes to corresponding CM-hDPSC donors for the increased cell numbers of exudate-exposed cells compared to controls. All prCM-hDPSC samples were prepared in parallel with CM-hDPSCs. For each experiment, the average experimental output value of the effect of prCM-hDPSCs was calculated and compared to CM-hDPSC. prCM-hDPSCs was collected from hDPSCs primed with 3 different L-PRF donors which were both kept consistent within each experiment.

2.7. Isolation and Culture of Mouse NSCs

Mouse NSCs were isolated from 6 foetal brains as described previously by Conti et al. [36] with minor modifications based on Reekmans et al. [37]. At gestational days 14-15, pregnant C57BL/6JOlaHsd mice (Envigo, Cambridgeshire, UK) were sacrificed by cervical dislocation and the foetuses were removed from the abdomen as approved by the ethical commission of Hasselt University (201410K). All experiments were conducted in accordance with the guidelines and regulations of the institute. Subsequently, the brains were removed and cut into small fragments in cold (4°C) PBS with 100 U/ml penicillin and 100 μg/ml streptomycin. The brain fragments were then transferred to a new vial and centrifuged for 8 min at 200 g. Afterwards, the supernatant was removed and incubated with 0.2% collagenase A (Roche, Basel, Switzerland) and DNase-I (2000 Kunitz units/50 ml) in PBS for 1.5 h at 37°C. The obtained dissociated tissue was subsequently washed and resuspended in Neurobasal-A medium supplemented with 1% N2 (Invitrogen), 10 ng/ml epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) (both from ImmunoTools, Friesoythe, Germany), 100 U/ml penicillin, and 100 μg/ml streptomycin. The cell suspension was then rinsed through a 70 μm cell strainer and transferred to an uncoated culture flask to allow neurosphere formation and removal of unwanted, plastic adherent cells. The neurospheres were allowed to grow for 4-5 days at 37°C in a humidified atmosphere containing 5% CO2, and the growth factors were replenished every other day. Neurosphere collection occurred by centrifugation at 200 g for 6 min followed by dissociation with Accutase for 5 min. Subsequently, the obtained NSCs were seeded at cells/cm2 on a 5 μg/ml fibronectin- (R&D Systems, Minneapolis, MN, USA) coated surface in Neurobasal-A medium supplemented with 2% B27 without vitamin A (Invitrogen), 10 ng/ml EGF and bFGF, 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin which will be referred to as standard NSC medium. The culture medium was changed every 3 to 4 days and cells were subcultured when 70-80% confluence was reached. NSCs were harvested by incubation with Accutase for 5 min (37°C) and centrifuged for 5 min at 300 g. For immunocytochemical (ICC) analysis, the NSCs were seeded at cells/cm2 on fibronectin-coated glass coverslips or on coated Thermanox® plastic coverslips for transmission electron microscopy (TEM) processing. Immunophenotyping of all NSC lines () was performed for the markers described in Reekmans et al. [37]. One representative NSC line was used in the subsequent experiments.

2.8. Transwell Migration Assay

Tissue culture inserts (ThinCert™, 8 μm pore size, Greiner Bio-One) were coated with 5 μg/ml fibronectin and seeded with NSCs ( cells/insert) in Neurobasal-A medium containing 0.2% B27, 2 mM L-glutamine, 10 ng/ml bFGF and EGF, 100 U/ml penicillin, and 100 μg/ml streptomycin. The bottom chemoattractant compartment of the well plate contained either CM-hDPSCs or prCM-hDPSCs () to which 0.2% B27 and 10 ng/ml EGF and bFGF were freshly added. As a negative (nonchemoattractant) control, Neurobasal-A medium containing 0.2% B27, 2 mM L-glutamine, 10 ng/ml bFGF and EGF, 100 U/ml penicillin, and 100 μg/ml streptomycin was added. The same medium containing 2% B27, 10 ng/ml EGF and bFGF, and 100 ng/ml SDF-1 (ImmunoTools) was used as a positive control. After 24 h, the transmigrated cells were fixed with 4% paraformaldehyde (PFA) and stained with 0.1% crystal violet. Data were collected from 4 independent experiments, and two representative micrographs were taken per insert. Migration was quantified with AxioVision software (Carl Zeiss, Aalen, Germany).

2.9. Metabolic Activity and Proliferation of NSCs

The metabolic and mitotic activities of NSCs exposed to CM-hDPSCs or prCM-hDPSCs () were evaluated by means of 6 independent MTT and PI assays, respectively. NSCs were seeded in 96-well plates at a density of cells/cm2 in standard NSC medium. After 24 h, the cells were exposed to the experimental conditions and both assays were performed 24 h, 48 h, and 72 h later as described previously (vide supra). To all experimental conditions, 0.2% B27 and 10 ng/ml EGF and bFGF were added. As internal controls, NSCs were exposed to standard NSC medium with 0.2% B27 instead of 2% and standard NSC medium with 20 ng/ml of EGF and bFGF to serve as a negative and positive control, respectively. All data were normalized to NSCs exposed to standard NSC medium with 0.2% B27 after 24 h exposure.

2.10. Isolation of Primary Cortical Neurons

Mouse pCNs were isolated from foetal brains () by an adapted protocol, based on [38]. At gestational days 17-18, pregnant C57BL/6JOlaHsd mice (Envigo) were sacrificed by cervical dislocation and the foetuses were removed from the abdomen as approved by the ethical commission of Hasselt University (201410K). All experiments were conducted in accordance with the guidelines and regulations of the institute. Subsequently, the brains were removed and put into preheated Hank’s balanced salt solution (HBSS; Invitrogen) supplemented with 7 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; Invitrogen), 100 U/ml penicillin, and 100 μg/ml streptomycin. Afterwards, the meninges were carefully removed with forceps under a Leica S6E stereomicroscope (Leica Microsystems, Wetzlar, Germany) and the cortex was dissected clear from the hippocampus, the thalamus, and the striatum. The obtained cortices were collected in HBSS/HEPES and incubated with 0.05% trypsin for 15 min at 37°C. The cortices were then washed three times with minimum essential medium (MEM; Invitrogen) supplemented with 10% horse serum (Invitrogen), 0.6% glucose, 100 U/ml penicillin, and 100 μg/ml streptomycin and were mechanically dissociated. The acquired cell suspension was centrifuged for 8 min at 300 g, and the cells were resuspended in supplemented MEM medium and rinsed through a 70 μM cell strainer to obtain a single-cell suspension. Neurons were seeded at 2.5 × 104 cells/cm2 on coverslips previously coated with 20 μg/ml poly-d-lysine (Corning; Corning, NY, USA).

2.11. Immunocytochemistry

Cells seeded on glass coverslips were fixed in 4% PFA, and immunostainings were performed according to a standardized protocol [4, 7]. In summary, in the case of an intracellular epitope, cells were permeabilized with 0.05% Triton X-100 in PBS at 4°C for 30 minutes. Afterwards, 10% donkey serum was used to block nonspecific binding sites. Cells were incubated at room temperature for 1 hour with the primary antibodies listed in Table 1. Afterwards, cells were incubated with the appropriate secondary antibody at room temperature for 30 minutes. Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI), and coverslips were mounted with antifade mounting medium (Dako, Glostrup, Denmark) on glass slides. Negative controls were included in each staining in which the staining procedure was performed in parallel with the other samples but with omission of the primary antibody. Micrographs were taken with a Nikon Eclipse 80i fluorescence microscope equipped with a 2MBWc digital sight camera and NIS-Elements software.


MarkerSpeciesClone, Cat no.DilutionLabelCompany

Primary antibodies
A2B5MMMAB312R1/200Millipore, Billerica, MA, USA
BLBPRPABN141/250Millipore
β-III tubulinRPab182071/50Abcam, Cambridge, UK
β-III tubulinMM2G101/2000Sigma-Aldrich
CD45RPAb633901/100Abcam
GFAPMMClone G-A-51/400Sigma-Aldrich
NCAMRPAb50321/100Millipore
NeuNMMA60, MAB3771/100Millipore
Sca-1GPAF12261/50R&D, Minneapolis, MN, USA
Sox2RPAb979591/1000Abcam
Secondary antibodies
DAMDP IgGA315701/500Alexa Fluor 555Invitrogen, Carlsbad, CA, USA
DARDP IgGA212061/500Alexa Fluor 488Invitrogen
DAGDP IgGA110551/500Alexa Fluor 488Invitrogen

BLBP: brain lipid-binding protein; GFAP: glial fibrillary acidic protein; NCAM: neural cell adhesion molecule; NeuN: neuronal nuclei; Sca-1: stem cell antigen-1; MM: mouse monoclonal antibody; RP: rabbit polyclonal antibody; GP: goat polyclonal; DP: donkey polyclonal; DAM: donkey anti-mouse; DAR: donkey anti-rabbit; DAG: donkey anti-goat.
2.12. Transmission Electron Microscopy

Cells cultured on plastic Thermanox® coverslips were prepared for ultrastructural analysis as previously described [4]. Briefly, postfixation of cells fixed with 2% glutaraldehyde was performed with 2% osmium tetroxide in 0.05 M sodium cacodylate buffer () at 4°C for 1 hour. Dehydration of the samples was performed by ascending concentrations of acetone. The dehydrated samples were impregnated overnight in a 1 : 1 mixture of acetone and araldite epoxy resin at room temperature. After impregnation, samples were embedded in araldite epoxy resin at 60°C using the pop-off method. Embedded samples were cut in slices of 40-60 nm with a Leica EM UC6 microtome (Leica, Wetzlar, Germany) and transferred to 0.7% formvar-coated copper grids (Aurion, Wageningen, the Netherlands). The samples were contrasted with 0.5% uranyl acetate and a stabilized solution of lead citrate using a Leica EM AC20 (Leica). TEM analysis was performed with a Philips EM208 S electron microscope (Philips, Eindhoven, the Netherlands) equipped with a Morada Soft Imaging System camera with corresponding iTEM-FEI software (Olympus SIS, Münster, Germany).

2.13. Neuritogenesis Assay of pCNs

After freshly isolated pCNs ( cells/cm2) adhered to the glass coverslips, the plating medium (minimum essential medium supplemented with 10% horse serum (Invitrogen), 0.6% glucose, 100 U/ml penicillin, and 100 μg/ml streptomycin) was changed to CM-hDPSCs or prCM-hDPSCs () to which 2% B27 with Vitamin A was freshly added. pCNs in standard pCN medium were used as controls. After 72 h, the pCNs were fixed with 4% PFA and an ICC staining was performed for β-III tubulin. Automated Neurite Outgrowth Assay 6.1 software (NEO 6.1; DCI Labs, Keerbergen, Belgium) was applied to evaluate neurite length and the number of neurites per pCN. The mean length of the longest neurite was calculated with Fiji software [39] with the NeuronJ plugin [40]. For each sample analysed with Fiji, at least 50 neurites were counted and only clearly distinguishable neurites were measured. For prCM-hDPSCs, the average neurite length of primed CM of 5 different hDPSC donors was calculated, primed with 3 different L-PRF donors. Simultaneously, the fraction of β-III tubulin-positive cells was evaluated to determine the neuronal purity of the obtained pCN culture. As an indication for network formation between pCNs exposed to CM-hDPSCs and prCM-hDPSCs, the number of cells making contact with one or more neighbouring cells in β-III tubulin-stained pCNs was evaluated with Fiji software. All experiments were performed on cultures of 3 independent pCN isolations.

2.14. Statistical Analysis

Statistical analysis was performed using GraphPad Prism 7 software (GraphPad, San Diego, CA, USA). Normality was checked with the Shapiro-Wilk test. Normal distributed data were tested with one-way ANOVA and Bonferroni’s multiple comparison posttest. Nonparametric data were analysed with the Kruskal-Wallis test followed by Dunn’s test. Differences were considered statistically significant at values ≤ 0.05. Data were expressed as error of the mean (SEM).

3. Results

3.1. Characterization of the L-PRF Secretome

The growth factors in the different L-PRF fractions () were investigated using an antibody array (Figure 2), which was previously used by our research group and published in Ratajczak et al. [35]. A reinterpretation of these arrays focusing on the inflammatory factors is presented in this study. Both CM L-PRF (Figure 2(a)) and EX L-PRF (Figure 2(b)) contained several inflammatory mediators which were shown to influence stem cell characteristics, including IL-1α, IL-1β, IL-6, IL-10, IGF-1, IFN-γ, TNF-α, and monocyte chemotactic protein-1 (MCP-1), albeit with high donor variability. Therefore, multiple L-PRF donors were included in subsequent priming experiments. Semiquantitative analysis of the relative pixel density of these proteins of interest suggested that none of these mediators were more abundant in either L-PRF fractions (Figure 2(c)) as depicted by green squares in Figures 2(a) and 2(b).

3.2. CM and EX L-PRF Stimulated hDPSC Proliferation

In order to evaluate the influence of CM and EX L-PRF on hDPSC metabolism and proliferation, an MTT and PI test was performed 24 h, 48 h, and 72 h after exposure (Figure 3). CM L-PRF had an inverse effect on hDPSC metabolism (Figure 3(a)) and hDPSC proliferation (Figure 3(b)). Higher concentrations of CM L-PRF (5% and 10%) significantly decreased hDPSC metabolism at every time point down to 51.25%-65.05% of the reference values measured after 24 h ( values ≤ 0.05, ≤ 0.01, and ≤ 0.001). On the other hand, 10% CM L-PRF significantly stimulated (- value ≤ 0.01) hDPSC proliferation up to 2.5-fold after 72 h. Low concentrations of EX L-PRF (1%, 2%, and 5%) significantly decreased hDPSC metabolism down to after 24 h ( value ≤ 0.001), but this effect was diminished 48 h and 72 h later where only 1% EX L-PRF significantly decreased hDPSC metabolism ( value ≤ 0.05; ≤ 0.01) (Figure 3(c)). The highest concentration of EX L-PRF (10%) significantly increased ( value ≤ 0.01) metabolism 1.43-fold after 72 h. When cell numbers were evaluated with PI, no decrease in cell numbers could be observed. While no effect was observed after 24 h, 5% and 10% EX L-PRF significantly enhanced hDPSC proliferation ( value ≤ 0.05; ≤ 0.01) after 48 h and 72 h (Figure 3(d)). 10% EX L-PRF increased hDPSC proliferation 3.7-fold, while the positive control increased hDPSC number 2.7-fold.

3.3. Priming of hDPSCs with L-PRF Altered Their BDNF Secretion

The CM of hDPSCs primed with various concentrations of CM and EX L-PRF for 24 h or 48 h was collected and subjected to an ELISA for BDNF as a measure for neurotrophin production (Figure 3(e)). 24 h priming with 10% CM L-PRF ( value ≤0.01) and 5% and 10% EX L-PRF ( value ≤ 0.05; ≤ 0.01) significantly enhanced BDNF production from to maximum per hDPSCs compared to nonprimed (hDPSCs exposed to α-MEM with 0% FBS). A significant increase in BDNF production after 48 h priming could only be observed when hDPSCs were primed with 10% CM or EX L-PRF ( value ≤ 0.05), increasing the BDNF concentration from to per hDPSCs.

3.4. Morphological and Immunocytological Characteristics of NSCs

Neurosphere-cultured NSCs were dissociated and the single-cell suspension was transferred to fibronectin-coated flasks to allow adherent cell culture. Cells presented with a large perikaryon with peripheral halo that typically acquired a bipolar or multipolar morphology with intercellular extensions (Figure 4(a)). Ultrastructurally, these cells were characterized by a large nucleus with prominent nucleolus (Figure 4(b)) and the cytoplasm contained several multivesicular bodies (MVBs) (Figure 4(c), insert).

NSCs were immunophenotyped for the NSC markers Sox2, NCAM, BLBP, GFAP, and A2B5 (Figures 4(d)4(h)). The obtained NSCs did not express markers of a more mature neuronal phenotype such as β-III tubulin and NeuN (Figures 4(i) and 4(j)) and did not express the hematopoietic marker CD45 and the mesenchymal marker Sca-1 (Figures 4(k) and 4(l)).

3.5. The hDPSC Secretome Acts as a Chemoattractant on NSCs

The chemoattractant properties of primed- and nonprimed hDPSCs were evaluated by means of a transwell migration assay. Representative micrographs of 0.1% crystal violet inserts of the experimental conditions are shown in Figure 5(a). Both CM-hDPSCs and prCM-hDPSCs significantly attracted NSCs after 24 h incubation ( value ≤ 0.05) (Figure 5(b)). No significant difference was detected between CM-hDPSCs and prCM-hDPSCs.

3.6. CM-hDPSCs and prCM-hDPSCs Had No Effect on Mitotic and Metabolic Activity of NSCs

The effect of CM-hDPSCs and prCM-hDPSCs on NSC metabolism and proliferation was evaluated by means of an MTT and PI assay, respectively. CM-hDPSCs significantly stimulated NSC metabolism after 24 h exposure ( value ≤ 0.01), and although there appears to be a metabolism-stimulating effect after 48 h, this was not significant (Figure 5(c)), and the trend disappeared after 72 h exposure. Similarly, CM-hDPSCs and prCM-hDPSCs were not able to stimulate NSC proliferation (Figure 5(d)). No significant difference between CM-hDPSCs and prCM-hDPSCs could be observed in either assay.

3.7. CM-hDPSCs Promotes Neurite Outgrowth of pCNs

The effect of primed and nonprimed hDPSCs on pCN neurite outgrowth was evaluated by measuring the total neurite length per pCN (Figure 6(a)) and the mean length of the longest neurite (Figure 6(b)). CM-hDPSCs, but not prCM-hDPSCs, was able to stimulate neurite outgrowth in pCNs after 72 h (Figures 6(a) and 6(b)), increasing total neurite outgrowth per neuron from in controls to ( value: 0.0267) after CM-hDPSCs-exposure. Additional analysis demonstrated that the mean length of the longest neurite increased from in controls to after CM-hDPSC-exposure ( value: 0.0002). The fraction of pCNs that makes contact with one or more neighbouring pCNs was determined as a measure for network formation (Figure 6(c)). After exposure to either CM-hDPSCs or prCM-hDPSCs, pCNs significantly increased the percentage of cells contributing to a network from in controls to ( value: 0.004) and ( value: 0.004), respectively. Interestingly, these effects of CM-hDPSCs and prCM-hDPSCs are not due to an increase in the number of neurites per pCN, as these numbers are not significantly altered after exposure of pCNs to both stimulants (Figure 6(d)). Moreover, the fraction of β-III tubulin-positive cells (control: ) was not significantly altered by adding CM-hDPSCs or prCM-hDPSCs to these cultures, maintaining the neuronal content of the culture (Figure 6(e)). Additionally, to evaluate neuronal survival over the 72 h period, the amount of pyknotic β-III tubulin-positive cells was also examined. CM-hDPSCs or prCM-hDPSCs did not have an effect on pCN cell death (Figure 6(f)). Representative micrographs of the control, CM-hDPSC-stimulated, and prCM-hDPSC-exposed pCNs are presented in Figures 6(g)6(i), respectively.

4. Discussion

Plausible mechanisms via which (mesenchymal) stem cells mediate neuronal repair in response to CNS damage include paracrine-induced chemoattraction and proliferation of endogenous NSCs in addition to stimulating the formation of new neuronal connections. This study evaluated paracrine-mediated neuroregenerative mechanisms of hDPSCs on in vitro expanded and characterized NSCs and pCNs. In addition, this study was aimed at invigorating the neuroregenerative potential of the hDPSC secretome by preconditioning or priming the cells with L-PRF. This clinically applicable autologous biomaterial was hypothesized to enhance the growth factor secretion pattern of hDPSCs.

In the first phase, the presence of inflammatory mediators of the L-PRF subfractions (CM and EX L-PRF) was determined, and the effect of L-PRF on hDPSCs was evaluated. Both CM and EX L-PRF contained inflammatory mediators such as TNF-α, IFN-γ, IL-1α, IL-1β, IGF-1, and IL-10 which were previously shown to influence MSC characteristics [2428, 30, 31]. In addition, IL-6 and MCP-1 were also found in the L-PRF subfractions and the latter was shown to enhance stem cell-mediated angiogenesis [41]. A detailed analysis of the differentially expressed factors in CM and EX L-PRF can be found in Ratajczak et al. [35] but was out of the scope of this study.

CM and EX L-PRF had an inverse effect on hDPSC metabolism. High concentrations of CM L-PRF significantly decreased the metabolism of hDPSCs, which was increased by high concentrations of EX L-PRF. Both subfractions of the L-PRF secretome stimulated hDPSC proliferation, which can be explained by the platelet-derived components that are present in CM and EX L-PRF as platelet lysates are often used as serum replacement in cell culture [42]. Moreover, it is possible that the concentration of platelet components is higher in EX L-PRF than in CM L-PRF which can explain the larger effect of EX L-PRF on hDPSC proliferation than CM L-PRF. Furthermore, the presented data suggest that the observed decrease in metabolic activity is an effect of CM and EX L-PRF on hDPSC metabolism, as no effect of the L-PRF subfractions on cell death was observed in the PI assay. Moreover, based on the semiquantitative analysis of the inflammatory mediators in CM and EX L-PRF, no significant difference in the level of mediators between both subfractions could be detected. This suggests that the observed differences in metabolic activity between CM and EX L-PRF-treated hDPSCs are not due to the level of the (analysed) inflammatory mediators. In addition, these contradicting results using the MTT- and PI assay emphasise that both tests are inherently different and have different readout parameters although the MTT test is often used as an assay to measure cell proliferation. A reason for the discrepancy in metabolic activity is unknown. Candidate factors might include those components that alter mitochondrial function and subsequently the MTT assay such as leukocyte-derived myeloperoxidases [43], TNF-α [23], and IL-1β [22] which lead to reactive oxygen species production [44].

Next, hDPSCs were primed with different concentrations of CM and EX L-PRF and BDNF secretion was taken as a measure for increased neurotrophin production. Priming hDPSCs for 24 h or 48 h with 10% CM or EX L-PRF significantly enhanced BDNF production by hDPSCs. However, due to the negative effect of CM L-PRF on hDPSC metabolism, 10% EX L-PRF was subsequently used to prime hDPSCs.

The proliferative and chemoattractant properties of CM-hDPSCs and prCM-hDPSCs on NSCs were evaluated next. The NSCs applied in this study showed the immunophenotype for the markers described in Reekmans et al. [37]. In accordance with previous data on the effect of CM-hDPSCs on SH-SY5Y cells [14], CM-hDPSCs did not influence NSC proliferation or metabolic activity and priming hDPSCs with L-PRF did not alter this response. CM-hDPSCs and prCM-hDPSCs were used to evaluate their chemoattractant properties on NSCs in a transwell assay as recruitment of endogenous NSC to the site of neuronal injury is one of the goals in neuroregenerative medicine. CM-hDPSCs significantly promoted NSC migration but again, this ability was not improved by L-PRF priming. Factors secreted by hDPSCs that can be responsible for this chemoattractive effect on NSCs include MCP-1 [45, 46], IL-8 [45, 47], and SDF-1 [48].

Finally, the neuritogenic potential of the secretome of primed and nonprimed hDPSCs on pCNs was evaluated as these are key aims for therapies targeting CNS regeneration. CM-hDPSCs but not prCM-hDPSCs was able to promote neuritogenesis in pCNs compared to controls in standard pCN medium. Moreover, both conditioned media did not significantly influence the purity of the neuronal culture or the number of pyknotic cells, excluding cytotoxic effects of the conditioned media. The factors responsible in the CM-hDPSCs for enhanced neurite outgrowth include the factors working via tyrosine receptor kinases (Trk). These include but are not limited to nerve growth factor, NT-3, BDNF, glial-derived growth factor, and VEGF [7, 32, 49].

Despite the efforts that were made to enhance the secretome of hDPSCs by L-PRF priming, no additional effect on neuroregenerative mechanisms was observed by priming hDPSCs with L-PRF. It can therefore be concluded that L-PRF priming does not alter the hDPSC secretome to a more favourable composition for neuroregeneration. Nonetheless, the priming effect on distinct fields of regenerative medicine remains to be elucidated. L-PRF components such as MCP-1, IL-8, and TNF-α were previously shown to enhance MSC-mediated angiogenesis [27, 41, 50] whereas IL-10, IFN-γ, IL-α, and IL-1β were shown to stimulate the immunomodulatory properties of MSCs [28, 30, 31]. Future hDPSC priming studies with the cocktail of growth factors present in the L-PRF subfractions should therefore focus on other regenerative mechanisms associated with wound healing. Moreover, it should be noted that in this study, a fairly young population of hDPSC donors was used (14-26 years of age) which were able to produce conditioned medium with neuroregenerative effects. Considering that autologous stem cell therapies should also be applicable for the elderly population, this raises concern on the potency of hDPSCs derived from older donors to produce comparable conditioned medium. While this was out of scope of this study, contradicting studies on the matter of age-related differences in hDPSCs are available. On the one hand, Feng et al. and Ma et al. demonstrated that age decreases the proliferation rate, migration, and osteogenic differentiation potential of DPSCs [51, 52]. On the other hand, several studies report that age does not influence the gene expression profile of DPSCs and that the stem cell properties and regenerative potential of DPSCs are independent of donor age [5355]. Despite these reports that suggest that age does not influence the regenerative potential of hDPSCs, no information on age-related differences in the composition of CM-hDPSC is available.

A final remark that can be made is that we demonstrated that L-PRF subfractions, and more specifically EX L-PRF, stimulate hDPSC proliferation when used as a medium supplement comparable to standard culture conditions using FCS. This is of particular interest as ideally, stem cells for clinical grade applications should be cultured in xeno-free conditions that significantly stimulate cell growth to obtain sufficient cell numbers in a short time period due to the genetic instability that arises in long-term cell culturing [56, 57]. Additionally, a recent report by Haque and Abu Kasim demonstrated that the use of FCS can influence the composition of the conditioned medium derived from stem cells from human extracted deciduous teeth compared to the secretome of these cells cultured in human serum [58]. Therefore, due to the ease and speed of blood-derived EX L-PRF isolation, it offers a potential autologous serum replacement strategy to supplement the culture medium that is needed for the in vitro expansion period that is often required before sufficient autologous stem cell numbers can be obtained for regenerative purposes. These findings are in line with Greiner et al., who demonstrated the successful use of human blood plasma as an additive for the culture of human neural crest-derived inferior turbinate stem cells which in addition did not influence the stem cell characteristics and differentiation potential of these cells [57]. Therefore, future studies that are aimed at using (EX) L-PRF as a serum replacement strategy for standard stem cell culture should evaluate the prolonged effect of L-PRF subfractions on the genetic stability, secretome composition, the stem cell properties, and differentiation potential of hDPSCs. However, this was beyond the scope of the present study.

In conclusion, the present study demonstrated the paracrine-mediated neuroregenerative potential of hDPSCs on NSC proliferation and migration and on stimulating pCN neurite outgrowth. Moreover, the effect of preconditioning hDPSCs with L-PRF which was hypothesized to improve the neuroregenerative potential of the hDPSC secretome was investigated. This approach has to our knowledge not been used before. The results in this study demonstrated that the CM of hDPSCs was capable to enhance neuritogenesis in pCNs. Moreover, this CM had a chemoattractant effect on NSCs but did not stimulate NSC proliferation. Although priming hDPSCs had no additional effect on the paracrine-mediated mechanisms of neuroregeneration described in this study, the potential of L-PRF-primed hDPSCs on distinct regenerative mechanisms remains to be clarified.

Data Availability

The datasets analysed during the current study are available from the corresponding author on reasonable request.

Disclosure

Part of this work has been previously presented as a poster presentation and abstract on the 4th Annual Meeting of the Belgian Society for Stem Cell Research on November 24th, 2017, Liège, Belgium.

Conflicts of Interest

Annelies Bronckaers is a member of the editorial board of Stem Cells International. Pascal Gervois is a postdoctoral researcher of the Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen. The other authors declare no conflict of interest.

Authors’ Contributions

P.G., E.W., and I.L. participated in the design and coordination of the project. P.G. collected, analysed, and interpreted the data and wrote the manuscript. J.R., Y.D., T.V., and G.M. contributed to the collection, analysis, and interpretation of the data. J.R. created Figure 1. E.W., A.B., and I.L. provided expert interpretation of the data. All authors have revised and approved the final manuscript.

Acknowledgments

The authors would like to send out a word of gratitude to Mr. Marc Jans for his expertise in preparing TEM samples and to Dr. Dearbhaile Dooley for her help with the isolation of NSCs. Pascal Gervois, Esther Wolfs, Jessica Ratajczak, Tim Vangansewinkel, Yörg Dillen, Annelies Bronckaers, and Ivo Lambrichts are funded by FWO grants 12U7718N, G0A7514N, G089213N, G029112N, 1134717N, 1508015N, and G026112N. Greet Merckx is supported by Bijzonder Onderzoeksfonds grant BOF16DOC06.

References

  1. Writing Group Members, D. Mozaffarian, E. J. Benjamin et al., “Heart disease and stroke statistics-2016 update: a report from the American Heart Association,” Circulation, vol. 133, no. 4, pp. e38–360, 2016. View at: Publisher Site | Google Scholar
  2. B. Reynolds and S. Weiss, “Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system,” Science, vol. 255, no. 5052, pp. 1707–1710, 1992. View at: Publisher Site | Google Scholar
  3. M. Dominici, K. le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at: Publisher Site | Google Scholar
  4. P. Hilkens, P. Gervois, Y. Fanton et al., “Effect of isolation methodology on stem cell properties and multilineage differentiation potential of human dental pulp stem cells,” Cell and Tissue Research, vol. 353, no. 1, pp. 65–78, 2013. View at: Publisher Site | Google Scholar
  5. T. Struys, M. Moreels, W. Martens, R. Donders, E. Wolfs, and I. Lambrichts, “Ultrastructural and immunocytochemical analysis of multilineage differentiated human dental pulp- and umbilical cord-derived mesenchymal stem cells,” Cells, Tissues, Organs, vol. 193, no. 6, pp. 366–378, 2011. View at: Publisher Site | Google Scholar
  6. S. Gronthos, J. Brahim, W. Li et al., “Stem cell properties of human dental pulp stem cells,” Journal of Dental Research, vol. 81, no. 8, pp. 531–535, 2016. View at: Publisher Site | Google Scholar
  7. P. Gervois, T. Struys, P. Hilkens et al., “Neurogenic maturation of human dental pulp stem cells following neurosphere generation induces morphological and electrophysiological characteristics of functional neurons,” Stem Cells and Development, vol. 24, no. 3, pp. 296–311, 2015. View at: Publisher Site | Google Scholar
  8. W. Martens, K. Sanen, M. Georgiou et al., “Human dental pulp stem cells can differentiate into Schwann cells and promote and guide neurite outgrowth in an aligned tissue-engineered collagen construct in vitro,” The FASEB Journal, vol. 28, no. 4, pp. 1634–1643, 2014. View at: Publisher Site | Google Scholar
  9. K. Sakai, A. Yamamoto, K. Matsubara et al., “Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms,” The Journal of Clinical Investigation, vol. 122, no. 1, pp. 80–90, 2012. View at: Publisher Site | Google Scholar
  10. A. Yamamoto, K. Sakai, K. Matsubara, F. Kano, and M. Ueda, “Multifaceted neuro-regenerative activities of human dental pulp stem cells for functional recovery after spinal cord injury,” Neuroscience Research, vol. 78, pp. 16–20, 2014. View at: Publisher Site | Google Scholar
  11. C. Z. Fang, Y. J. Yang, Q. H. Wang, Y. Yao, X. Y. Zhang, and X. H. He, “Intraventricular injection of human dental pulp stem cells improves hypoxic-ischemic brain damage in neonatal rats,” PLoS One, vol. 8, no. 6, article e66748, 2013. View at: Publisher Site | Google Scholar
  12. W. K. Leong, T. L. Henshall, A. Arthur et al., “Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms,” Stem Cells Translational Medicine, vol. 1, no. 3, pp. 177–187, 2012. View at: Publisher Site | Google Scholar
  13. P. Gervois, E. Wolfs, J. Ratajczak et al., “Stem cell-based therapies for ischemic stroke: preclinical results and the potential of imaging-assisted evaluation of donor cell fate and mechanisms of brain regeneration,” Medicinal Research Reviews, vol. 36, no. 6, pp. 1080–1126, 2016. View at: Publisher Site | Google Scholar
  14. P. Gervois, E. Wolfs, Y. Dillen et al., “Paracrine maturation and migration of SH-SY5Y cells by dental pulp stem cells,” Journal of Dental Research, vol. 96, no. 6, pp. 654–662, 2017. View at: Publisher Site | Google Scholar
  15. J. Ratajczak, P. Hilkens, P. Gervois et al., “Angiogenic capacity of periodontal ligament stem cells pretreated with deferoxamine and/or fibroblast growth factor-2,” PLoS One, vol. 11, no. 12, article e0167807, 2016. View at: Publisher Site | Google Scholar
  16. A. M. F. Aranha, Z. Zhang, K. G. Neiva, C. A. S. Costa, J. Hebling, and J. E. Nör, “Hypoxia enhances the angiogenic potential of human dental pulp cells,” Journal of Endodontia, vol. 36, no. 10, pp. 1633–1637, 2010. View at: Publisher Site | Google Scholar
  17. N. E.-M. B. Ahmed, M. Murakami, S. Kaneko, and M. Nakashima, “The effects of hypoxia on the stemness properties of human dental pulp stem cells (DPSCs),” Scientific Reports, vol. 6, no. 1, article 35476, 2016. View at: Publisher Site | Google Scholar
  18. H. D. Muller, B. Cvikl, R. Gruber, G. Watzek, and H. Agis, “Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor in dental pulp-derived cells,” Journal of Endodontia, vol. 38, no. 11, pp. 1498–1503, 2012. View at: Publisher Site | Google Scholar
  19. F. Munoz, C. Jimenez, D. Espinoza, A. Vervelle, J. Beugnet, and Z. Haidar, “Use of leukocyte and platelet-rich fibrin (L-PRF) in periodontally accelerated osteogenic orthodontics (PAOO): clinical effects on edema and pain,” Journal of Clinical and Experimental Dentistry, vol. 8, no. 2, pp. e119–e124, 2016. View at: Publisher Site | Google Scholar
  20. G. Marenzi, F. Riccitiello, M. Tia, A. di Lauro, and G. Sammartino, “Influence of leukocyte- and platelet-rich fibrin (L-PRF) in the healing of simple postextraction sockets: a split-mouth study,” BioMed Research International, vol. 2015, Article ID 369273, 6 pages, 2015. View at: Publisher Site | Google Scholar
  21. D. M. D. Ehrenfest, T. Bielecki, R. Jimbo et al., “Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF),” Current Pharmaceutical Biotechnology, vol. 13, no. 7, pp. 1145–1152, 2012. View at: Publisher Site | Google Scholar
  22. M. O. Schar, J. Diaz-Romero, S. Kohl, M. A. Zumstein, and D. Nesic, “Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro,” Clinical Orthopaedics and Related Research, vol. 473, no. 5, pp. 1635–1643, 2015. View at: Publisher Site | Google Scholar
  23. D. M. Dohan, J. Choukroun, A. Diss et al., “Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 101, no. 3, pp. e51–e55, 2006. View at: Publisher Site | Google Scholar
  24. M. Ueda, T. Fujisawa, M. Ono et al., “A short-term treatment with tumor necrosis factor-alpha enhances stem cell phenotype of human dental pulp cells,” Stem Cell Research & Therapy, vol. 5, no. 1, p. 31, 2014. View at: Publisher Site | Google Scholar
  25. V. Egea, L. von Baumgarten, C. Schichor et al., “TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma,” Cell Death and Differentiation, vol. 18, no. 5, pp. 853–863, 2011. View at: Publisher Site | Google Scholar
  26. Y. L. Huang, R. F. Qiu, W. Y. Mai et al., “Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro,” Journal of Zhejiang University. Science. B, vol. 13, no. 1, pp. 20–28, 2012. View at: Publisher Site | Google Scholar
  27. Y. W. Kwon, S. C. Heo, G. O. Jeong et al., “Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1832, no. 12, pp. 2136–2144, 2013. View at: Publisher Site | Google Scholar
  28. H. Fan, G. Zhao, L. Liu et al., “Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis,” Cellular & Molecular Immunology, vol. 9, no. 6, pp. 473–481, 2012. View at: Publisher Site | Google Scholar
  29. W. D. Hill, D. C. Hess, A. Martin-Studdard et al., “SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury,” Journal of Neuropathology and Experimental Neurology, vol. 63, no. 1, pp. 84–96, 2004. View at: Publisher Site | Google Scholar
  30. J. Y. Lim, K. I. Im, E. S. Lee et al., “Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis,” Scientific Reports, vol. 6, no. 1, article 26851, 2016. View at: Publisher Site | Google Scholar
  31. E. Redondo-Castro, C. Cunningham, J. Miller et al., “Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro,” Stem Cell Research & Therapy, vol. 8, no. 1, p. 79, 2017. View at: Publisher Site | Google Scholar
  32. B. Mead, A. Logan, M. Berry, W. Leadbeater, and B. A. Scheven, “Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells,” PLoS One, vol. 9, no. 10, article e109305, 2014. View at: Publisher Site | Google Scholar
  33. M. Ploughman, V. Windle, C. L. MacLellan, N. White, J. J. Dore, and D. Corbett, “Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats,” Stroke, vol. 40, no. 4, pp. 1490–1495, 2009. View at: Publisher Site | Google Scholar
  34. W.-R. Schäbitz, T. Steigleder, C. M. Cooper-Kuhn et al., “Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis,” Stroke, vol. 38, no. 7, pp. 2165–2172, 2007. View at: Publisher Site | Google Scholar
  35. J. Ratajczak, T. Vangansewinkel, P. Gervois et al., “Angiogenic properties of ‘leukocyte- and platelet-rich fibrin’,” Scientific Reports, vol. 8, no. 1, article 14632, 2018. View at: Publisher Site | Google Scholar
  36. L. Conti, S. M. Pollard, T. Gorba et al., “Niche-independent symmetrical self-renewal of a mammalian tissue stem cell,” PLoS Biology, vol. 3, no. 9, article e283, 2005. View at: Publisher Site | Google Scholar
  37. K. P. Reekmans, J. Praet, N. De Vocht et al., “Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice?” Cell Transplantation, vol. 20, no. 6, pp. 851–870, 2011. View at: Publisher Site | Google Scholar
  38. G. Banker and K. Goslin, Culturing Nerve Cells, vol. 666, MIT Press, Cambridge, MA, USA, 2nd edition, 1998.
  39. J. Schindelin, I. Arganda-Carreras, E. Frise et al., “Fiji: an open-source platform for biological-image analysis,” Nature Methods, vol. 9, no. 7, pp. 676–682, 2012. View at: Publisher Site | Google Scholar
  40. E. Meijering, M. Jacob, J. C. F. Sarria, P. Steiner, H. Hirling, and M. Unser, “Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images,” Cytometry. Part A, vol. 58A, no. 2, pp. 167–176, 2004. View at: Publisher Site | Google Scholar
  41. Y. Hayashi, M. Murakami, R. Kawamura, R. Ishizaka, O. Fukuta, and M. Nakashima, “CXCL14 and MCP1 are potent trophic factors associated with cell migration and angiogenesis leading to higher regenerative potential of dental pulp side population cells,” Stem Cell Research & Therapy, vol. 6, no. 1, p. 111, 2015. View at: Publisher Site | Google Scholar
  42. H. Hemeda, B. Giebel, and W. Wagner, “Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells,” Cytotherapy, vol. 16, no. 2, pp. 170–180, 2014. View at: Publisher Site | Google Scholar
  43. T. Finkel, “Oxidant signals and oxidative stress,” Current Opinion in Cell Biology, vol. 15, no. 2, pp. 247–254, 2003. View at: Publisher Site | Google Scholar
  44. D. Yang, S. G. Elner, Z. M. Bian, G. O. Till, H. R. Petty, and V. M. Elner, “Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells,” Experimental Eye Research, vol. 85, no. 4, pp. 462–472, 2007. View at: Publisher Site | Google Scholar
  45. A. Bronckaers, P. Hilkens, Y. Fanton et al., “Angiogenic properties of human dental pulp stem cells,” PLoS One, vol. 8, no. 8, article e71104, 2013. View at: Publisher Site | Google Scholar
  46. D. Widera, W. Holtkamp, F. Entschladen et al., “MCP-1 induces migration of adult neural stem cells,” European Journal of Cell Biology, vol. 83, no. 8, pp. 381–387, 2004. View at: Publisher Site | Google Scholar
  47. N. Weiss, C. Deboux, N. Chaverot et al., “IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells,” Journal of Neuroimmunology, vol. 223, no. 1-2, pp. 131–134, 2010. View at: Publisher Site | Google Scholar
  48. A. Arthur, S. Shi, A. C. W. Zannettino, N. Fujii, S. Gronthos, and S. A. Koblar, “Implanted adult human dental pulp stem cells induce endogenous axon guidance,” Stem Cells, vol. 27, no. 9, pp. 2229–2237, 2009. View at: Publisher Site | Google Scholar
  49. A. M. Davies, “Neurotrophins: neurotrophic modulation of neurite growth,” Current Biology, vol. 10, no. 5, pp. R198–R200, 2000. View at: Publisher Site | Google Scholar
  50. Y. Hou, C. H. Ryu, J. A. Jun, S. M. Kim, C. H. Jeong, and S. S. Jeun, “IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor,” Cell Biology International, vol. 38, no. 9, pp. 1050–1059, 2014. View at: Publisher Site | Google Scholar
  51. X. Feng, J. Xing, G. Feng et al., “p16(INK4A) mediates age-related changes in mesenchymal stem cells derived from human dental pulp through the DNA damage and stress response,” Mechanisms of Ageing and Development, vol. 141-142, pp. 46–55, 2014. View at: Publisher Site | Google Scholar
  52. D. Ma, Z. Ma, X. Zhang et al., “Effect of age and extrinsic microenvironment on the proliferation and osteogenic differentiation of rat dental pulp stem cells in vitro,” Journal of Endodontia, vol. 35, no. 11, pp. 1546–1553, 2009. View at: Publisher Site | Google Scholar
  53. H. Horibe, M. Murakami, K. Iohara et al., “Isolation of a stable subpopulation of mobilized dental pulp stem cells (MDPSCs) with high proliferation, migration, and regeneration potential is independent of age,” PLoS One, vol. 9, no. 5, article e98553, 2014. View at: Publisher Site | Google Scholar
  54. M. Kellner, M. M. Steindorff, J. F. Strempel, A. Winkel, M. P. Kuhnel, and M. Stiesch, “Differences of isolated dental stem cells dependent on donor age and consequences for autologous tooth replacement,” Archives of Oral Biology, vol. 59, no. 6, pp. 559–567, 2014. View at: Publisher Site | Google Scholar
  55. E. Bressan, L. Ferroni, C. Gardin et al., “Donor age-related biological properties of human dental pulp stem cells change in nanostructured scaffolds,” PLoS One, vol. 7, no. 11, article e49146, 2012. View at: Publisher Site | Google Scholar
  56. R. Izadpanah, D. Kaushal, C. Kriedt et al., “Long-term in vitro expansion alters the biology of adult mesenchymal stem cells,” Cancer Research, vol. 68, no. 11, pp. 4229–4238, 2008. View at: Publisher Site | Google Scholar
  57. J. F. Greiner, S. Hauser, D. Widera et al., “Efficient animal-serum free 3D cultivation method for adult human neural crest-derived stem cell therapeutics,” European Cells & Materials, vol. 22, pp. 403–419, 2011. View at: Publisher Site | Google Scholar
  58. N. Haque and N. H. Abu Kasim, “Pooled human serum increases regenerative potential of in vitro expanded stem cells from human extracted deciduous teeth,” Advances in Experimental Medicine and Biology, vol. 1083, pp. 29–44, 2017. View at: Publisher Site | Google Scholar

Copyright © 2019 Pascal Gervois et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

936 Views | 382 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.